Login to Your Account



Novacea Licenses Cancer Drug From KuDOS Pharmaceuticals

By Randall Osborne


Friday, December 12, 2003
Novacea Inc. in-licensed a Phase I cancer drug known as AQ4N from KuDOS Pharmaceuticals Inc., gaining North American rights in exchange for undisclosed development milestone payments and royalties. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription